News

INCOG BioPharma Services announces it has completed the construction of its Quality Control testing laboratories, as well as the technology transfer and scale-up suite, at its headquarters in Fishers, Indiana. Shortly after INCOG employees moved into their new offices,...

Biocon Biologics Ltd., a subsidiary of Biocon Ltd., announced that it has entered into a definitive agreement with its partner Viatris Inc. Accordingly, Biocon Biologics Ltd. (BBL) will acquire Viatris’ biosimilars business to create a unique fully integrated global...

Biohaven Pharmaceutical Holding Company Ltd. announced that it entered into a worldwide license agreement with Bristol Myers Squibb for the development and commercialization rights to taldefgrobep alfa, a novel, Phase 3-ready anti-myostatin adnectin. Taldefgrobep is the third development asset...

Mirus Bio, a leading provider of delivery solutions within Gamma Biosciences, today launched TransIT-VirusGEN® SELECT Transfection Kits for large-scale viral vector production for cell and gene therapy applications. The kits support pre-clinical and process development activities and consist of...

The Chronic Obstructive Pulmonary Disease Foundation, or COPD, has stepped forward to help Ena Respiratory, an Australian clinical-stage pharma company, to develop an antiviral nasal spray targeting chronic lung disease patients. Ena is getting ready to conduct phase 2...

Varicose veins are swollen, twisted veins that bulge on the surface of the skin. Many adults in America have them and it is treated as a common condition around the world. Several experts and research institutions often consider them as...

Varicose veins are a common problem among adults in America. In fact, approximately 24% of adults living in America have visible varicose veins. With that, many patients are now turning to surgeons and vein specialists to have them removed. There...